跳至主要内容
临床试验/EUCTR2013-005309-30-IT
EUCTR2013-005309-30-IT进行中(未招募)1 期

open label, randomized, pilot study on the activity of olanzapine with or without delayed dexamenthasone versus dexamenthasone alone for the prevention of delayed nausea and vomiting in patients with gynecologic cancers receiving carboplatin and paclitaxel-based chemotherapy and guidline-directed prophylactic anti-emetics

Fondazione IRCCS Istituto Nazionale dei Tumori0 个研究点目标入组 75 人开始时间: 2014年1月14日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • patient with diagnosis of gynecologic cancer not pretreate with chemoterapy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 45

排除标准

  • patients scheduled to receive chemotherapy, brain metastases, patients who receive another antipsychotic agent, performance status >2

研究者

相似试验

open label, randomized, pilot study on the activity... | 临床试验